Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

medicalnewstoday.com

1 of 0

Resource Description:

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment

« Back to the Peramivir WisdomCard

Related Health Centers:

Advertisement